ConductScience.org, home

Paper40161350

MicroRNA-99 family in cancer: molecular mechanisms for clinical applications.

Wang Y and 3 others. PeerJ, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. MicroRNA-99 family in cancer: molecular mechanisms for clinical applications. Papers, record 40161350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40161350

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MicroRNA-99 family in cancer: molecular mechanisms for clinical applications.
PubMed
Journal
PeerJ
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.37, provisional
iCite
Revised in PubMed
2025-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYueyuan
2Huang DDan
3Li MMingxi
4Yang MMing

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
NeoplasmsMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Humans
Apoptosis
Biomarkers, Tumor
Carcinogenesis

Source PubMed

Download CSV of topics

References255

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130903488Changes in the Metastatic Properties of MDA-MB-231 Cells after IGFBP6 Gene Knockdown Is Associated with Increased Expression of miRNA Genes Controlling INSR, IGF1R, and CCND1 Genes.Bull Exp Biol Med2019https://conductscience.org/library/papers/30903488PubMed
218774294The let-7 family of microRNAs.Trends Cell Biol2008https://conductscience.org/library/papers/18774294PubMed
337582734Serum lncRNA THRIL predicts benign and malignant pulmonary nodules and promotes the progression of pulmonary malignancies.BMC Cancer2023https://conductscience.org/library/papers/37582734PubMed
427158394Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.Am J Transl Res2016https://conductscience.org/library/papers/27158394PubMed
530981762MicroRNA-125 in immunity and cancer.Cancer Lett2019https://conductscience.org/library/papers/30981762PubMed
629035371lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling.Nat Med2017https://conductscience.org/library/papers/29035371PubMed
728642484miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.Sci Rep2017https://conductscience.org/library/papers/28642484PubMed
827081843Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.Mol Med Rep2016https://conductscience.org/library/papers/27081843PubMed
932911741Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer.Genes (Basel)2020https://conductscience.org/library/papers/32911741PubMed
1020484036Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.Cancer Res2010https://conductscience.org/library/papers/20484036PubMed
1131164632The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.Cell Death Dis2019https://conductscience.org/library/papers/31164632PubMed
1236764156Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer.Comput Biol Med2023https://conductscience.org/library/papers/36764156PubMed
1335720506miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD.Oncol Lett2022https://conductscience.org/library/papers/35720506PubMed
1432152275HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p.Cell Death Dis2020https://conductscience.org/library/papers/32152275PubMed
1533198772Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.J Exp Clin Cancer Res2020https://conductscience.org/library/papers/33198772PubMed
1622167321Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22167321PubMed
1727748936miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin.Oncol Rep2016https://conductscience.org/library/papers/27748936PubMed
1837184125Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma.Cancer Med2023https://conductscience.org/library/papers/37184125PubMed
1924805183Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.Int J Oncol2014https://conductscience.org/library/papers/24805183PubMed
2029296717Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.Blood Adv2017https://conductscience.org/library/papers/29296717PubMed

See all 255 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42481967Non-invasive diagnostic evaluation of urinary exosomal let-7c cluster expression in bladder cancer using machine learning approaches.BMC Cancer2026https://conductscience.org/library/papers/42481967PubMed
42100432miR-99b-5p inhibition drives apoptosis and tumor shrinkage in triple-negative breast cancer: functional characterization through AGO2-RIP-seq and mechanistic insights.Front Oncol2026https://conductscience.org/library/papers/42100432PubMed
42064128Expression profile of miR-99a and miR-218 across oral submucous fibrosis and oral squamous cell carcinoma.J Oral Maxillofac Pathol2026https://conductscience.org/library/papers/42064128PubMed
41096589Stefin A Regulation of Cathepsin B Expression and Localization in Cancerous and Non-Cancerous Cells.Int J Mol Sci2025https://conductscience.org/library/papers/41096589PubMed
40641110MicroRNA‑21: A potential therapeutic target in lung cancer (Review).Int J Oncol2025https://conductscience.org/library/papers/40641110PubMed
40462168The lncrna HMMR-AS1 promotes the malignant progression of ovarian cancer cells by regulating the miR-627-3p/PTN axis.J Ovarian Res2025https://conductscience.org/library/papers/40462168PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MIR100406892PubTator's text mininghttps://conductscience.org/library/genes/406892NCBI Gene
MIR99A407055PubTator's text mininghttps://conductscience.org/library/genes/407055NCBI Gene
MIR99B407056PubTator's text mininghttps://conductscience.org/library/genes/407056NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40161350

GET https://conductscience.org/api/papers/v1/40161350/references?page=2